Gabon vs Libya: Antiretroviral therapy coverage for PMTCT
Gabon
72.0%
in 2024
Libya
70.0%
in 2023
Gabon rank
49th
Libya rank
51st
Antiretroviral therapy coverage for PMTCT over time
- Gabon
- Libya
How they compare
Gabon currently reports 72.0% against 70.0% in Libya, a difference of 2.0%.
The two have swapped places 4 times across 18 shared years of data; in 2000 it was Libya ahead.
Gabon ranks 49th and Libya ranks 51st of 84 countries.
Across the 3 decades both report, Gabon averaged higher in 1 and Libya in 2.
Head to head by decade
| Decade | Gabon | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.6% | 0.0% | 6.6% | Gabon |
| 2010s | 65.0% | 65.8% | 0.8% | Libya |
| 2020s | 70.2% | 71.0% | 0.8% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Gabon or Libya?
- Gabon, at 72.0% against 70.0% in Libya as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Gabon and Libya?
- 2.0%, with Gabon ahead.
- How many years of comparable data are there for Gabon and Libya?
- 18 years are reported by both, from 2000 to 2023.
- How do Gabon and Libya rank globally for antiretroviral therapy coverage for pmtct?
- Gabon ranks 49th and Libya ranks 51st of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).